Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Shridhar V, Rivard S, Shridhar R, Mullins C, Bostick L, Sakr W, Grignon D, Miller OJ, Smith DI. A gene from human chromosomal band 3p21.1 encodes a highly conserved arginine-rich protein and is mutated in renal cell carcinomas. Oncogene. 1996 May 2;12(9):1931-9. PubMed PMID: 8649854.
Paradee W, Wilke CM, Wang L, Shridhar R, Mullins CM, Hoge A, Glover TW, Smith DI. A 350-kb cosmid contig in 3p14.2 that crosses the t(3;8) hereditary renal cell carcinoma translocation breakpoint and 17 aphidicolin-induced FRA3B breakpoints. Genomics. 1996 Jul 1;35(1):87-93. doi: 10.1006/geno.1996.0326. PubMed PMID: 8661108.
Shridhar R, Shridhar V, Wang X, Paradee W, Dugan M, Sarkar F, Wilke C, Glover TW, Vaitkevicius VK, Smith DI. Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors. Cancer Res. 1996 Oct 1;56(19):4347-50. PubMed PMID: 8813121.
Shridhar R, Shridhar V, Rivard S, Siegfried JM, Pietraszkiewicz H, Ensley J, Pauley R, Grignon D, Sakr W, Miller OJ, Smith DI. Mutations in the arginine-rich protein gene, in lung, breast, and prostate cancers, and in squamous cell carcinoma of the head and neck. Cancer Res. 1996 Dec 15;56(24):5576-8. PubMed PMID: 8971156.
Shridhar V, Wang L, Rosati R, Paradee W, Shridhar R, Mullins C, Sakr W, Grignon D, Miller OJ, Sun QC, Petros J, Smith DI. Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas. Oncogene. 1997 Mar 20;14(11):1269-77. doi: 10.1038/sj.onc.1201100. PubMed PMID: 9178887.
Wang L, Paradee W, Mullins C, Shridhar R, Rosati R, Wilke CM, Glover TW, Smith DI. Aphidicolin-induced FRA3B breakpoints cluster in two distinct regions. Genomics. 1997 May 1;41(3):485-8. doi: 10.1006/geno.1997.4690. PubMed PMID: 9169152.
Shridhar V, Rivard S, Wang X, Shridhar R, Paisley C, Mullins C, Beirnat L, Dugan M, Sarkar F, Miller OJ, Vaitkevicius VK, Smith DI. Mutations in the arginine-rich protein gene (ARP) in pancreatic cancer. Oncogene. 1997 May 8;14(18):2213-6. doi: 10.1038/sj.onc.1201054. PubMed PMID: 9174057.
Shridhar R, Zhang J, Song J, Booth BA, Kevil CG, Sotiropoulou G, Sloane BF, Keppler D. Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells. Oncogene. 2004 Mar 18;23(12):2206-15. doi: 10.1038/sj.onc.1207340. PubMed PMID: 14676833.
Zhang J, Shridhar R, Dai Q, Song J, Barlow SC, Yin L, Sloane BF, Miller FR, Meschonat C, Li BD, Abreo F, Keppler D. Cystatin m: a novel candidate tumor suppressor gene for breast cancer. Cancer Res. 2004 Oct 1;64(19):6957-64. doi: 10.1158/0008-5472.CAN-04-0819. PubMed PMID: 15466187.
Song J, Jie C, Polk P, Shridhar R, Clair T, Zhang J, Yin L, Keppler D. The candidate tumor suppressor CST6 alters the gene expression profile of human breast carcinoma cells: down-regulation of the potent mitogenic, motogenic, and angiogenic factor autotaxin. Biochem Biophys Res Commun. 2006 Feb 3;340(1):175-82. doi: 10.1016/j.bbrc.2005.11.171. Epub 2005 Dec 9. PubMed PMID: 16356477.
Chien J, Narita K, Rattan R, Giri S, Shridhar R, Staub J, Beleford D, Lai J, Roberts LR, Molina J, Kaufmann SH, Prendergast GC, Shridhar V. A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation. Oncogene. 2008 Dec 11;27(58):7223-34. doi: 10.1038/onc.2008.360. Epub 2008 Sep 22. PubMed PMID: 18806825; PubMed Central PMCID: PMC2754286.
Chien J, Ota T, Aletti G, Shridhar R, Boccellino M, Quagliuolo L, Baldi A, Shridhar V. Serine protease HtrA1 associates with microtubules and inhibits cell migration. Mol Cell Biol. 2009 Aug;29(15):4177-87. doi: 10.1128/MCB.00035-09. Epub 2009 May 26. PubMed PMID: 19470753; PubMed Central PMCID: PMC2715801.
Shridhar R, Bolton S, Joiner MC, Forman JD. Dose escalation using a hypofractionated, intensity-modulated radiation therapy boost for localized prostate cancer: preliminary results addressing concerns of high or low alpha/beta ratio. Clin Genitourin Cancer. 2009 Oct;7(3):E52-7. doi: 10.3816/CGC.2009.n.024. PubMed PMID: 19815482.
Hoffe SE, Shridhar R, Biagioli MC. Radiation therapy for rectal cancer: current status and future directions. Cancer Control. 2010 Jan;17(1):25-34. doi: 10.1177/107327481001700104. Review. PubMed PMID: 20010516.
Shridhar R, Estabrook W, Yudelev M, Rakowski J, Burmeister J, Wilson GD, Joiner MC. Characteristic 8 keV X rays possess radiobiological properties of higher-LET radiation. Radiat Res. 2010 Mar;173(3):290-7. doi: 10.1667/RR1782.1. PubMed PMID: 20199214.
Rattan R, Narita K, Chien J, Maguire JL, Shridhar R, Giri S, Shridhar V. TCEAL7, a putative tumor suppressor gene, negatively regulates NF-kappaB pathway. Oncogene. 2010 Mar 4;29(9):1362-73. doi: 10.1038/onc.2009.431. Epub 2009 Dec 7. PubMed PMID: 19966855.
Hoffe SE, Finkelstein SE, Russell MS, Shridhar R. Nonsurgical options for hepatocellular carcinoma: evolving role of external beam radiotherapy. Cancer Control. 2010 Apr;17(2):100-10. doi: 10.1177/107327481001700205. Review. PubMed PMID: 20404793.
Melis M, Weber JM, McLoughlin JM, Siegel EM, Hoffe S, Shridhar R, Turaga KK, Dittrick G, Dean EM, Karl RC, Meredith KL. An elevated body mass index does not reduce survival after esophagectomy for cancer. Ann Surg Oncol. 2011 Mar;18(3):824-31. doi: 10.1245/s10434-010-1336-1. Epub 2010 Sep 24. PubMed PMID: 20865331; PubMed Central PMCID: PMC4623586.
Chuong MD, Hayman TJ, Patel MR, Russell MS, Malafa MP, Hodul PJ, Springett GM, Choi J, Shridhar R, Hoffe SE. Comparison of 1-, 2-, and 3-Dimensional Tumor Response Assessment After Neoadjuvant GTX-RT in Borderline-Resectable Pancreatic Cancer. Gastrointest Cancer Res. 2011 Jul;4(4):128-34. PubMed PMID: 22368736; PubMed Central PMCID: PMC3283109.
Shridhar R, Dombi GW, Finkelstein SE, Meredith KL, Hoffe SE. Improved survival in patients with lymph node-positive gastric cancer who received preoperative radiation: an analysis of the Surveillance, Epidemiology, and End Results database. Cancer. 2011 Sep 1;117(17):3908-16. doi: 10.1002/cncr.25995. Epub 2011 Mar 1. PubMed PMID: 21365627.
Robinson J, Opp D, Zhang G, Cashon K, Kozelka J, Hunt D, Walker L, Hoffe S, Shridhar R, Feygelman V. Evaluating dosimetric accuracy of flattening filter free compensator-based IMRT: measurements with diode arrays. Med Phys. 2012 Jan;39(1):342-52. doi: 10.1118/1.3671936. PubMed PMID: 22225304.
Dittrick GW, Weber JM, Shridhar R, Hoffe S, Melis M, Almhanna K, Barthel J, McLoughlin J, Karl RC, Meredith KL. Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy. Ann Surg Oncol. 2012 May;19(5):1678-84. doi: 10.1245/s10434-011-2078-4. Epub 2011 Nov 2. PubMed PMID: 22045465.
Shridhar R, Dombi GW, Weber J, Hoffe SE, Meredith K, Konski A. Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis. Am J Clin Oncol. 2012 Jun;35(3):216-21. doi: 10.1097/COC.0b013e31820dbf08. PubMed PMID: 21378540.
Shridhar R, Hayman T, Hoffe SE, Weber J, Almhanna K, Chuong M, Karl RC, Meredith KL. Body mass index and survival in esophageal adenocarcinoma treated with chemoradiotherapy followed by esophagectomy. J Gastrointest Surg. 2012 Jul;16(7):1296-302. doi: 10.1007/s11605-012-1843-4. Epub 2012 Mar 8. PubMed PMID: 22399271.
Fernandez DC, Hoffe SE, Barthel JS, Vignesh S, Klapman JB, Harris C, Almhanna K, Biagioli MC, Meredith KL, Feygelman V, Rao NG, Shridhar R. Stability of endoscopic ultrasound-guided fiducial marker placement for esophageal cancer target delineation and image-guided radiation therapy. Pract Radiat Oncol. 2013 Jan-Mar;3(1):32-39. doi: 10.1016/j.prro.2012.02.006. Epub 2012 Mar 30. PubMed PMID: 24674261.
Chuong MD, Freilich JM, Hoffe SE, Fulp W, Weber JM, Almhanna K, Dinwoodie W, Rao N, Meredith KL, Shridhar R. Intensity-Modulated Radiation Therapy vs. 3D Conformal Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal. Gastrointest Cancer Res. 2013 Mar;6(2):39-45. PubMed PMID: 23745158; PubMed Central PMCID: PMC3674462.
Saeed N, Latifi K, Hoffe SE, Cruz A, Opp DW, Moros EG, Zhang GG, Budzevich MM, Shridhar R, Dilling TJ. Optimizing Options for Re-irradiation With Deformable Image Registration of Prior Plans. Pract Radiat Oncol. 2013 Apr-Jun;3(2 Suppl 1):S16-7. doi: 10.1016/j.prro.2013.01.060. Epub 2013 Mar 25. PubMed PMID: 24674497.
Vignesh S, Hoffe SE, Meredith KL, Shridhar R, Almhanna K, Gupta AK. Endoscopic therapy of neoplasia related to Barrett's esophagus and endoscopic palliation of esophageal cancer. Cancer Control. 2013 Apr;20(2):117-29. doi: 10.1177/107327481302000205. Review. PubMed PMID: 23571702.
Shridhar R, Almhanna K, Meredith KL, Biagioli MC, Chuong MD, Cruz A, Hoffe SE. Radiation therapy and esophageal cancer. Cancer Control. 2013 Apr;20(2):97-110. doi: 10.1177/107327481302000203. Review. PubMed PMID: 23571700.
Almhanna K, Meredith KL, Hoffe SE, Shridhar R, Coppola D. Targeting the human epidermal growth factor receptor 2 in esophageal cancer. Cancer Control. 2013 Apr;20(2):111-6. doi: 10.1177/107327481302000204. Review. PubMed PMID: 23571701.
Wong JY, Shridhar R, Almhanna K, Hoffe SE, Karl RC, Meredith KL. The impact of body mass index on esophageal cancer. Cancer Control. 2013 Apr;20(2):138-43. doi: 10.1177/107327481302000207. Review. PubMed PMID: 23571704.
Almhanna K, Shridhar R, Meredith KL. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: is there a standard of care?. Cancer Control. 2013 Apr;20(2):89-96. doi: 10.1177/107327481302000202. Review. PubMed PMID: 23571699.
Shridhar R, Almhanna K, Hoffe SE, Fulp W, Weber J, Chuong MD, Meredith KL. Increased survival associated with surgery and radiation therapy in metastatic gastric cancer: a Surveillance, Epidemiology, and End Results database analysis. Cancer. 2013 May 1;119(9):1636-42. doi: 10.1002/cncr.27927. Epub 2013 Jan 29. PubMed PMID: 23361968.
Melis M, Weber J, Shridhar R, Hoffe S, Almhanna K, Karl RC, Meredith KL. Body mass index and perioperative complications after oesophagectomy for adenocarcinoma: a systematic database review. BMJ Open. 2013 May 2;3(5). doi: 10.1136/bmjopen-2012-001336. PubMed PMID: 23645908; PubMed Central PMCID: PMC3646172.
Rao NG, Han G, Greene JN, Tanvetyanon T, Kish JA, De Conti RC, Chuong MD, Shridhar R, Biagioli MC, Caudell JJ, Trotti AM 3rd. Effect of prophylactic fluconazole on oral mucositis and candidiasis during radiation therapy for head-and-neck cancer. Pract Radiat Oncol. 2013 Jul-Sep;3(3):229-233. doi: 10.1016/j.prro.2012.05.008. Epub 2012 Jun 21. PubMed PMID: 24674369.
Chuong MD, Springett GM, Freilich JM, Park CK, Weber JM, Mellon EA, Hodul PJ, Malafa MP, Meredith KL, Hoffe SE, Shridhar R. Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated. Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):516-22. doi: 10.1016/j.ijrobp.2013.02.022. Epub 2013 Apr 5. PubMed PMID: 23562768.
Shridhar R, Weber J, Hoffe SE, Almhanna K, Karl R, Meredith K. Adjuvant radiation therapy and lymphadenectomy in esophageal cancer: a SEER database analysis. J Gastrointest Surg. 2013 Aug;17(8):1339-45. doi: 10.1007/s11605-013-2192-7. Epub 2013 Jun 8. PubMed PMID: 23749498.
Hernandez JM, Dimou F, Weber J, Almhanna K, Hoffe S, Shridhar R, Karl R, Meredith K. Defining the learning curve for robotic-assisted esophagogastrectomy. J Gastrointest Surg. 2013 Aug;17(8):1346-51. doi: 10.1007/s11605-013-2225-2. Epub 2013 May 21. PubMed PMID: 23690208.
Pimiento JM, Weber J, Hoffe SE, Shridhar R, Almhanna K, Vignesh S, Karl RC, Meredith KL. Outcomes associated with surgery for T4 esophageal cancer. Ann Surg Oncol. 2013 Aug;20(8):2706-12. doi: 10.1245/s10434-013-2885-x. Epub 2013 Mar 16. PubMed PMID: 23504118.
Chuong MD, Fernandez DC, Shridhar R, Hoffe SE, Saini A, Hunt D, Meredith KL, Biagioli MC. High-dose-rate endorectal brachytherapy for locally advanced rectal cancer in previously irradiated patients. Brachytherapy. 2013 Sep-Oct;12(5):457-62. doi: 10.1016/j.brachy.2012.11.003. Epub 2013 May 23. PubMed PMID: 23707855.
Wong J, Weber J, Almhanna K, Hoffe S, Shridhar R, Karl R, Meredith KL. Extent of lymphadenectomy does not predict survival in patients treated with primary esophagectomy. J Gastrointest Surg. 2013 Sep;17(9):1562-8; discussion 1569. doi: 10.1007/s11605-013-2259-5. Epub 2013 Jul 2. PubMed PMID: 23818125.
de la Fuente SG, Weber J, Hoffe SE, Shridhar R, Karl R, Meredith KL. Initial experience from a large referral center with robotic-assisted Ivor Lewis esophagogastrectomy for oncologic purposes. Surg Endosc. 2013 Sep;27(9):3339-47. doi: 10.1007/s00464-013-2915-6. Epub 2013 Apr 3. PubMed PMID: 23549761.
Shridhar R, Hoffe SE, Almhanna K, Weber JM, Chuong MD, Karl RC, Meredith K. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy. Ann Surg Oncol. 2013 Sep;20(9):3038-43. doi: 10.1245/s10434-013-2988-4. Epub 2013 Apr 28. PubMed PMID: 23625142.
Shridhar R, Imani-Shikhabadi R, Davis B, Streeter OA, Thomas CR Jr. Curative treatment of esophageal cancer; an evidenced based review. J Gastrointest Cancer. 2013 Dec;44(4):375-84. doi: 10.1007/s12029-013-9511-9. Review. PubMed PMID: 23824628.
Wong J, Rahman S, Saeed N, Lin HY, Almhanna K, Shridhar R, Hoffe S, Meredith KL. Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience. J Gastrointest Surg. 2013 Dec;17(12):2059-66. doi: 10.1007/s11605-013-2380-5. Epub 2013 Oct 16. PubMed PMID: 24129828.
Wong J, Rahman S, Saeed N, Lin HY, Almhanna K, Shridhar R, Hoffe S, Meredith KL. Effect of body mass index in patients undergoing resection for gastric cancer: a single center US experience. J Gastrointest Surg. 2014 Mar;18(3):505-11. doi: 10.1007/s11605-014-2455-y. Epub 2014 Jan 18. PubMed PMID: 24443204.
Opfermann KJ, Wahlquist AE, Garrett-Mayer E, Shridhar R, Cannick L, Marshall DT. Adjuvant radiotherapy and lymph node status for pancreatic cancer: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data. Am J Clin Oncol. 2014 Apr;37(2):112-6. doi: 10.1097/COC.0b013e31826e0570. PubMed PMID: 23211221; PubMed Central PMCID: PMC3594531.
Hoffe S, Rao N, Shridhar R. Neoadjuvant vs adjuvant therapy for resectable pancreatic cancer: the evolving role of radiation. Semin Radiat Oncol. 2014 Apr;24(2):113-25. doi: 10.1016/j.semradonc.2013.11.002. Review. PubMed PMID: 24635868.
Mellon EA, Springett GM, Hoffe SE, Hodul P, Malafa MP, Meredith KL, Fulp WJ, Zhao X, Shridhar R. Adjuvant radiotherapy and lymph node dissection in pancreatic cancer treated with surgery and chemotherapy. Cancer. 2014 Apr 15;120(8):1171-7. doi: 10.1002/cncr.28543. Epub 2014 Jan 3. PubMed PMID: 24390779.
Shridhar R, Freilich J, Hoffe SE, Almhanna K, Fulp WJ, Yue B, Karl RC, Meredith K. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus. Ann Surg Oncol. 2014 Nov;21(12):3744-50. doi: 10.1245/s10434-014-3795-2. Epub 2014 May 23. PubMed PMID: 24854492.
What would you like to do?